US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

  • Biopharmaceuticals (266)
  • Diseases & Conditions (4151)
  • Drug Delivery (287)
  • Therapeutic Area (7380)
  • Vaccines (728)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Biopharmaceutical and Vaccine Production Markets
8/29/2014 | published by: Kalorama Information
... final stages of clinical drug testing for new biopharmaceuticals, as manufacturers decide when and how to risk production capital to upscale while anticipating FDA or EMA approval. During the past five years, estimates for biopharmaceuticals ...  |  read more...
USD 3,995
RTI Biologics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' RTI Biologics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Gedeon Richter Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Gedeon Richter Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Santen Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Santen Pharmaceutical Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and ...  |  read more...
USD 350
Shire plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Shire plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
Premature Ejaculation - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... therapeutic development for Premature Ejaculation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... the Recurrent Head And Neck Cancer Squamous Cell Carcinoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Recurrent Head And Neck Cancer Squamous Cell Carcinoma, complete with comparative analysis at various ...  |  read more...
USD 2,000
Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Functional (Non Ulcer) Dyspepsia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Eosinophilic Esophagitis - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... therapeutic development for Eosinophilic Esophagitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Fatty Liver Disease - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... information on the therapeutic development for Fatty Liver Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... information on the therapeutic development for Paroxysmal Nocturnal Hemoglobinuria, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Bone Regeneration - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... therapeutic development for Bone Regeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Female Hypoactive Sexual Desire Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Keloids - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... Keloids, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Eczema - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... Eczema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Peptic Ulcers - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... therapeutic development for Peptic Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Herpes Zoster (Shingles) - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... information on the therapeutic development for Herpes Zoster (Shingles), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Hyperglycemia - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... Hyperglycemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Bronchopulmonary Dysplasia - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... therapeutic development for Bronchopulmonary Dysplasia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Axillary Hyperhidrosis - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... therapeutic development for Axillary Hyperhidrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Thrombotargets Corporation - Product Pipeline Review - 2014
9/15/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Thrombotargets Corporation’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Acetylon Pharmaceuticals, Inc. - Product Pipeline Review - 2014
9/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Acetylon Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Kaketsuken K.K. - Product Pipeline Review - 2014
9/15/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Kaketsuken K.K.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
NGM Biopharmaceuticals, Inc. - Product Pipeline Review - 2014
9/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of NGM Biopharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Presidio Pharmaceuticals, Inc. - Product Pipeline Review - 2014
9/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Presidio Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
< prev 1    3  4  5  6  7  8  9  10